Functional outcome and survival after radiotherapy of metastatic spinal cord compression in patients with cancer of unknown primary

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 2, 2007, Pages 532-537

  Rades, Dirk ^a   Fehlauer, Fabian ^b   Veninga, Theo ^c   Stalpers, Lukas J A ^d   Basic, Hiba ^e   Hoskin, Peter J ^f   Rudat, Volker ^g   Karstens, Johann H ^h   Schild, Steven E ⁱ   Dunst, Juergen ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e University Hospital   (Bosnia and Herzegovina)

^f MOUNT VERNON CANCER CENTRE   (United Kingdom)

^g ST JOSEF HOSPITAL   (Germany)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ MAYO CLINIC   (United States)

Author keywords

Cancer of unknown primary; Metastatic spinal cord compression; Radiotherapy

Indexed keywords

BONE; COST EFFECTIVENESS; RADIOTHERAPY; TUMORS;

AMBULATORY STATUS; METASTATIC SPINAL CORD COMPRESSION; PROGNOSTIC FACTORS;

PATIENT TREATMENT;

ADULT; AGED; AMBULATORY CARE; ARTICLE; BONE METASTASIS; CANCER; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH STATUS; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SHORT COURSE THERAPY; SPINAL CORD COMPRESSION; VISCERAL METASTASIS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; RADIOTHERAPY DOSAGE; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SPINAL CORD COMPRESSION; SPINAL NEOPLASMS;

EID: 33846259726     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.08.047     Document Type: Article

References (23)

1. Patchell R., Tibbs P.A., Regine W.F., et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomised trial. Lancet 366 (2005) 643-648
2. Maranzano E., and Latini P. Effectiveness of radiation therapy without surgery in metastatic spinal cord compression: Final results from a prospective trial. Int J Radiat Oncol Biol Phys 32 (1995) 959-967
3. Sørensen P.S., Børgesen S.E., Rohde K., et al. Metastatic epidural spinal cord compression. Cancer 65 (1990) 1502-1508
4. Hoskin P.J., Grover A., and Bhana R. Metastatic spinal cord compression: Radiotherapy outcome and dose fractionation. Radiother Oncol 68 (2003) 175-180
5. Prasad D., and Schiff D. Malignant spinal cord compression. Lancet Oncol 6 (2005) 15-24
6. Rades D., Stalpers L.J.A., Hulshof M.C., et al. Comparison of 1×8 Gy and 10×3 Gy for functional outcome in patients with metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 62 (2005) 514-518
7. Doll D.C., Ringenberg Q.S., Bickel J.T., et al. Epidural spinal cord compression as the presenting manifestation of tumor of unknown origin. Med Pediatr Oncol 18 (1990) 280-282
8. Tomita T., Galicich J.H., and Sundaresan N. Radiation therapy for spinal epidural metastases with complete block. Acta Radiol Oncol 22 (1983) 135-143
9. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
10. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 13-47
11. Bruner D.W., and Wasserman T. The impact on quality of life by radiation late effects. Int J Radiat Oncol Biol Phys 31 (1995) 1353-1355
12. Maranzano E., Latini P., Beneventi S., et al. Comparison of two different radiotherapy schedules for spinal cord compression in prostate cancer. Tumori 84 (1998) 472-477
13. Maranzano E., Bellavita R., Rossi R., et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: Results of a phase III, randomized, multicenter trial. J Clin Oncol 23 (2005) 3358-3365
14. Rades D., Stalpers L.J.A., Veninga T., et al. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 23 (2005) 3366-3375
15. Rades D., Veninga T., Stalpers L.J., et al. Prognostic factors predicting functional outcomes recurrence free survival, and overall survival after radiotherapy for metastatic spinal cord compression in breast cancer patients. Int J Radiat Oncol Biol Phys 64 (2006) 182-188
16. Rades D., Stalpers L.J., Veninga T., et al. Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. J Urol 175 (2006) 552-556
17. Rades D., Hoskin P.J., Stalpers L.J., et al. Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. Int J Radiat Oncol Biol Phys 64 (2006) 1452-1457
18. Manabe S., Tanaka H., Higo Y., et al. Experimental analysis of the spinal cord compressed by spinal metastasis. Spine 14 (1989) 1308-1315
19. Helweg-Larsen S., Sørensen P.S., and Kreiner S. Prognostic factors in metastatic spinal cord compression: A prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 46 (2000) 1163-1169
20. Loblaw D.A., and Lapierre N.J. Emergency treatment of malignant extradural spinal cord compression: An evidence-based guideline. J Clin Oncol 16 (1998) 1613-1624
21. Sorensen P.S., Helweg-Larsen S., Mouridsen H., et al. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: A randomized trial. Eur J Cancer 30A (1994) 22-27
22. Heimdal K., Hirschberg H., Slettebo H., et al. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol 12 (1992) 141-144
23. Van den Hout W.B., Van der Linden Y.M., Steenland E., et al. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: Cost-utility analysis based on a randomized trial. J Natl Cancer Inst 95 (2003) 222-229